Clinical Trial Update: A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease [NA]

View source ↗

Summary

The clinical trial evaluating oral paricalcitol for proteinuric renal disease has been withdrawn. The study record lists Winthrop University Hospital as sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proteinuric Renal Disease

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Winthrop University Hospital | Conditions: Proteinuric Renal Disease | NA | Status: WITHDRAWN